Submitted URL: https://e.endpointsnews.com/t/t-l-vtutjtd-jhdldljikl-k/
Effective URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-m...
Submission: On November 17 via api from US — Scanned from DE

Summary

This website contacted 26 IPs in 3 countries across 20 domains to perform 751 HTTP transactions. The main IP is 99.86.91.113, located in United States and belongs to AMAZON-02, US. The main domain is endpts.com. The Cisco Umbrella rank of the primary domain is 145764.
TLS certificate: Issued by Amazon RSA 2048 M03 on October 16th 2023. Valid for: a year.
This is the only time endpts.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 54.183.0.47 16509 (AMAZON-02)
39 99.86.91.113 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 50.17.168.97 14618 (AMAZON-AES)
1 2600:9000:205... 16509 (AMAZON-02)
2 2a02:26f0:350... 20940 (AKAMAI-ASN1)
124 2a00:1450:400... 15169 (GOOGLE)
1 2001:4860:480... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
4 2a00:1450:400... 15169 (GOOGLE)
1 2 2620:1ec:21::14 8068 (MICROSOFT...)
1 13.107.42.14 8068 (MICROSOFT...)
1 2600:1901:0:4... 15169 (GOOGLE)
1 52.4.243.120 14618 (AMAZON-AES)
1 2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
4 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 151.101.2.137 54113 (FASTLY)
1 52.84.106.92 16509 (AMAZON-02)
1 162.247.243.29 54113 (FASTLY)
2 52.84.106.112 16509 (AMAZON-02)
1 34.225.215.29 14618 (AMAZON-AES)
751 26
Apex Domain
Subdomains
Transfer
124 youtube.com
www.youtube.com — Cisco Umbrella Rank: 68
1014 KB
40 endpts.com
endpts.com — Cisco Umbrella Rank: 145764
api.stats.endpts.com — Cisco Umbrella Rank: 167474
1 MB
4 googleapis.com
jnn-pa.googleapis.com — Cisco Umbrella Rank: 207
32 KB
4 gstatic.com
fonts.gstatic.com
www.gstatic.com
48 KB
4 doubleclick.net
stats.g.doubleclick.net — Cisco Umbrella Rank: 78
googleads.g.doubleclick.net — Cisco Umbrella Rank: 33
static.doubleclick.net — Cisco Umbrella Rank: 255
1 KB
3 linkedin.com
px.ads.linkedin.com — Cisco Umbrella Rank: 377
px4.ads.linkedin.com — Cisco Umbrella Rank: 6003
2 KB
2 intercomcdn.com
js.intercomcdn.com — Cisco Umbrella Rank: 2317
274 KB
2 intercom.io
widget.intercom.io — Cisco Umbrella Rank: 1771
api-iam.intercom.io — Cisco Umbrella Rank: 2191
6 KB
2 google.com
region1.analytics.google.com — Cisco Umbrella Rank: 3040
www.google.com — Cisco Umbrella Rank: 2
16 KB
2 licdn.com
snap.licdn.com — Cisco Umbrella Rank: 778
19 KB
1 nr-data.net
bam.nr-data.net — Cisco Umbrella Rank: 225
400 B
1 newrelic.com
js-agent.newrelic.com — Cisco Umbrella Rank: 562
16 KB
1 ggpht.com
yt3.ggpht.com — Cisco Umbrella Rank: 219
2 KB
1 ytimg.com
i.ytimg.com — Cisco Umbrella Rank: 87
14 KB
1 chartbeat.net
ping.chartbeat.net — Cisco Umbrella Rank: 1376
201 B
1 mxpnl.com
cdn.mxpnl.com — Cisco Umbrella Rank: 3740
18 KB
1 google.de
www.google.de — Cisco Umbrella Rank: 6862
408 B
1 chartbeat.com
static.chartbeat.com — Cisco Umbrella Rank: 1585
15 KB
1 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 35
90 KB
1 endpointsnews.com
e.endpointsnews.com — Cisco Umbrella Rank: 405165
924 B
751 20
Domain Requested by
124 www.youtube.com endpts.com
www.youtube.com
39 endpts.com endpts.com
4 jnn-pa.googleapis.com www.youtube.com
2 js.intercomcdn.com widget.intercom.io
2 www.gstatic.com www.youtube.com
www.gstatic.com
2 googleads.g.doubleclick.net 1 redirects www.youtube.com
2 px.ads.linkedin.com 1 redirects snap.licdn.com
2 fonts.gstatic.com www.youtube.com
2 snap.licdn.com endpts.com
snap.licdn.com
1 api-iam.intercom.io js.intercomcdn.com
1 bam.nr-data.net js-agent.newrelic.com
1 widget.intercom.io endpts.com
1 js-agent.newrelic.com endpts.com
1 yt3.ggpht.com www.youtube.com
1 i.ytimg.com www.youtube.com
1 www.google.com www.youtube.com
1 static.doubleclick.net www.youtube.com
1 ping.chartbeat.net endpts.com
1 cdn.mxpnl.com endpts.com
1 px4.ads.linkedin.com endpts.com
1 www.google.de endpts.com
1 stats.g.doubleclick.net www.googletagmanager.com
1 region1.analytics.google.com www.googletagmanager.com
1 static.chartbeat.com endpts.com
1 api.stats.endpts.com endpts.com
1 www.googletagmanager.com endpts.com
1 e.endpointsnews.com 1 redirects
751 27
Subject Issuer Validity Valid
endpts.com
Amazon RSA 2048 M03
2023-10-16 -
2024-11-12
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
stats.endpts.com
Amazon RSA 2048 M02
2023-02-03 -
2024-03-03
a year crt.sh
*.chartbeat.com
Thawte TLS RSA CA G1
2023-05-16 -
2024-06-06
a year crt.sh
snap.licdn.com
DigiCert SHA2 Secure Server CA
2023-02-01 -
2024-01-31
a year crt.sh
*.google.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
www.google.de
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
*.mxpnl.com
GeoTrust TLS RSA CA G1
2023-07-12 -
2024-08-11
a year crt.sh
*.chartbeat.net
Thawte RSA CA 2018
2022-12-19 -
2023-12-30
a year crt.sh
*.doubleclick.net
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
upload.video.google.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
www.google.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
edgestatic.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
*.googleusercontent.com
GTS CA 1C3
2023-10-23 -
2024-01-15
3 months crt.sh
www.linkedin.com
DigiCert SHA2 Secure Server CA
2023-11-03 -
2024-05-03
6 months crt.sh
js-agent.newrelic.com
GlobalSign Atlas R3 DV TLS CA 2023 Q2
2023-04-13 -
2024-05-14
a year crt.sh
*.intercom.com
Amazon RSA 2048 M02
2023-02-14 -
2024-03-14
a year crt.sh
*.nr-data.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-09-29 -
2024-10-01
a year crt.sh
*.intercomcdn.com
Amazon RSA 2048 M01
2023-02-21 -
2024-01-29
a year crt.sh

This page contains 5 frames:

Primary Page: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Frame ID: 11006ADF387A1C9DC6051C7C3CAD7D9D
Requests: 55 HTTP requests in this frame

Frame: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Frame ID: EB2B5FF5973D758CAB4162ECEC992FB7
Requests: 244 HTTP requests in this frame

Frame: https://www.youtube.com/cspreport
Frame ID: 738D499BCEB79BA2FA3F48D25A7070AE
Requests: 224 HTTP requests in this frame

Frame: https://www.youtube.com/cspreport
Frame ID: 0D16A0CBA13FFA3A3A21B119A93572C5
Requests: 224 HTTP requests in this frame

Frame: https://js.intercomcdn.com/frame-modern.e128bf6a.js
Frame ID: 859823954DBA03E2FF70DF7DCEC0DE99
Requests: 3 HTTP requests in this frame

Screenshot

Page Title

Clinical Studies In Japan Today: Another Look At The World’s Second-Largest Prescription Drug Market In A Post-Pandemic World – Endpoints News

Page URL History Show full URLs

  1. https://e.endpointsnews.com/t/t-l-vtutjtd-jhdldljikl-k/ HTTP 302
    https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • /wp-(?:content|includes)/

Overall confidence: 100%
Detected patterns
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • chartbeat\.js

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

Overall confidence: 100%
Detected patterns
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

751
Requests

26 %
HTTPS

62 %
IPv6

20
Domains

27
Subdomains

26
IPs

3
Countries

2709 kB
Transfer

6633 kB
Size

13
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://e.endpointsnews.com/t/t-l-vtutjtd-jhdldljikl-k/ HTTP 302
    https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 277
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=2273916%2C5136028&time=1700242022405&url=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F%3Futm_medium%3Demail%26utm_campaign%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%26utm_content%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%2BCID_7bc57866ee1d8dfbb6c7e8af351448d3%26utm_source%3DENDPOINTS%2520emails%26utm_term%3DClinshyishycal%2520Studshyies%2520In%2520Japan%2520Toshyday%2520Anshyothshyer%2520Look%2520At%2520The%2520Worlds%2520Secshyond-Largest%2520Preshyscripshytion%2520Drug%2520Marshyket%2520In%2520A%2520Post-Panshydemshyic%2520World HTTP 302
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=2273916%2C5136028&time=1700242022405&url=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F%3Futm_medium%3Demail%26utm_campaign%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%26utm_content%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%2BCID_7bc57866ee1d8dfbb6c7e8af351448d3%26utm_source%3DENDPOINTS%2520emails%26utm_term%3DClinshyishycal%2520Studshyies%2520In%2520Japan%2520Toshyday%2520Anshyothshyer%2520Look%2520At%2520The%2520Worlds%2520Secshyond-Largest%2520Preshyscripshytion%2520Drug%2520Marshyket%2520In%2520A%2520Post-Panshydemshyic%2520World&e_ipv6=AQKNjzrczxHfAgAAAYveUmCRF2Ixsy1dE3utCKN4HVb60nhVOaNZ1kEDrXXP0IvCIvQU6ReTVXsj
Request Chain 281
  • https://googleads.g.doubleclick.net/pagead/id HTTP 302
  • https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

751 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/
Redirect Chain
  • https://e.endpointsnews.com/t/t-l-vtutjtd-jhdldljikl-k/
  • https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20...
118 KB
29 KB
Document
General
Full URL
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
d1dd1302dfd94c5b1b7c6b1e720dd8275aab2c41bc8be5e3e14c73c465926668
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
56
alt-svc
h3=":443"; ma=86400
content-encoding
gzip
content-length
28986
content-type
text/html; charset=UTF-8
date
Fri, 17 Nov 2023 17:26:05 GMT
link
<https://endpts.com/wp-json/>; rel="https://api.w.org/", <https://endpts.com/?p=436214>; rel=shortlink
referer
same-origin
referrer-policy
same-origin
strict-transport-security
max-age=2592000; includeSubDomains; preload
vary
Accept-Encoding
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-amz-cf-id
QLqvWBLNBdqT6g_Qnf-xsB7S4C_hu8mXeAc3Cddblp2lVpQsuP1geQ==
x-amz-cf-pop
CDG50-C1
x-cache
Hit from cloudfront
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-xss-protection
1; mode=block

Redirect headers

content-length
167
content-type
text/html
date
Fri, 17 Nov 2023 17:27:01 GMT
location
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
referrer-policy
no-referrer-when-downgrade
server
csw
x-content-type-options
nosniff
x-xss-protection
1; mode=block
bootstrap-grid-modal.min.css
endpts.com/wp-content/themes/endpoints-rakia/assets/css/bootstrap/
48 KB
8 KB
Stylesheet
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/bootstrap/bootstrap-grid-modal.min.css?ver=4.6.2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
9a82b82db4b282bd447aed035d53594406b383b4fd0db2ec8c06b0e7bc29da10
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:54:27 GMT
content-encoding
gzip
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
171154
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:42 GMT
etag
W/"655503c6-c143"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
iTp94ULD5v8O4ibUjn1byae6858i-qf9RBBifvJbgL2OcZZyysRr-Q==
expires
Wed, 22 Nov 2023 17:54:27 GMT
style.min.css
endpts.com/wp-content/themes/endpoints-rakia/assets/css/
208 KB
29 KB
Stylesheet
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
46a94b5ca8340f5331277dbb9227947947851addc87e15a7d12d25899b8f35fb
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:54:27 GMT
content-encoding
gzip
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
171155
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:43 GMT
etag
W/"655503c7-33eff"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
rY81dtsiFbdiU9STEB7N5CcIHj9M94Uz61Hx9I5JYWb8l71FHBUOxA==
expires
Wed, 22 Nov 2023 17:54:27 GMT
fonts.min.css
endpts.com/wp-content/themes/endpoints-rakia/assets/css/
5 KB
1 KB
Stylesheet
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/fonts.min.css?ver=361844066
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
cee26d6ab6b6db882f8673807bd8d4494fd9b2bb1ce45c3c81e5253e375b8eb0
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:54:27 GMT
content-encoding
gzip
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
171154
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:43 GMT
etag
W/"655503c7-1500"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
dmISuMf1KF-96i3ZhWuaWNTVHAOApBWcBHgOA4VY2ievwLQ0Wr6Ajw==
expires
Wed, 22 Nov 2023 17:54:27 GMT
IvarText_Regular.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
37 KB
38 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarText_Regular.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
9202ac2ba461536db435c2f7f5b90e592491e0ea34dce674a90608f39d09a586
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:56:37 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
171024
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
37904
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-9410"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
su_FwMu7dgbasVAs4bXml8i27P7wTI1FLyqujjRdefAFM2e6SsR7rA==
expires
Wed, 29 Nov 2023 17:56:37 GMT
IvarText_Bold.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
39 KB
40 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarText_Bold.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
6a3e07ab6500d966fc7e51620c10e7187475afb5179da4bfc71d0a9b542dc4ea
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
39912
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-9be8"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
rHKoZW67BJ06kzsJH9iZmfj0OW9g6xIk1j8YqxHLMoEayAwnSP5X1Q==
expires
Wed, 29 Nov 2023 17:57:06 GMT
IvarText_Italic.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
32 KB
33 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarText_Italic.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
7c3179748239e88358afab39ddd2b8c6aec9751b3454c0c3baa6263a661d6e7c
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
32844
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-804c"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
4AqKaoWL1m3ONmsVSvqK53yqMYGL0j-ZmyAM5u-V3BD0dMcdk-QHhQ==
expires
Wed, 29 Nov 2023 17:57:06 GMT
IvarHeadline_SemiBold.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
32 KB
33 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarHeadline_SemiBold.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
38592195d58d32dc3a2a5cc8d9305bcb08651bf4e98b453af084ac562edf2cd5
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
32708
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-7fc4"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
iIVjuChgsANZ5knY0e9g21zC_H-GaKTMZ4SZk2If1W3pNluqcoE1iw==
expires
Wed, 29 Nov 2023 17:57:06 GMT
Concourse_T4_Bold.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
24 KB
25 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_T4_Bold.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
c8cad36d821f1f751eccadd2f90e7efea669d5cb96253b2f3f444731f057e6ee
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
25084
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-61fc"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
SiKGphjDtlBwVE6v82leq6gPfn26_26ormhAV6_1UqgP2x8BHPTBqw==
expires
Wed, 29 Nov 2023 17:57:06 GMT
Concourse_T4_Italic.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
25 KB
26 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_T4_Italic.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
3458f412b94fda24599851f6be28747289d2b5675d06e0483a1fbf496df4bb5d
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
25948
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-655c"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
nhhP7EnsyUazHWmDBRpyuApca3jcT1EmfkRiGElVhPz-6s6MJGc2FQ==
expires
Wed, 29 Nov 2023 17:57:06 GMT
Concourse_C4_Bold.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
24 KB
25 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_C4_Bold.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
63f99eb0fc03242bc86a7b4ce768f820cf9a9ac1e690da8dd73d35c056c06085
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
24912
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-6150"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
T_b_diW5kU6OZxOkgvsa7_fxvxKDYSvLxZdwPCzCZBn6wa97gJiW2A==
expires
Wed, 29 Nov 2023 17:57:06 GMT
Concourse_C4_Regular.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
24 KB
25 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_C4_Regular.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
3ee8b2ee2019387f819fbd04c59bf269c6ec6544a60cea5eb323617776eb21fc
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
24652
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-604c"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
7xec8VwEHmIpazCqwr3hsyxds1iaDjMC0EdOkdZLG_peD0UuYboMlw==
expires
Wed, 29 Nov 2023 17:57:06 GMT
facets-styles.css
endpts.com/wp-content/plugins/elasticpress/dist/css/
5 KB
2 KB
Stylesheet
General
Full URL
https://endpts.com/wp-content/plugins/elasticpress/dist/css/facets-styles.css?ver=7d568203f3965dc85d8a
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
e6e49883534bf2c5d17497b4b3e93d5ac8381526e670d6e620018dadf85b90ea
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:54:25 GMT
content-encoding
gzip
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
171156
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 01 Nov 2023 18:08:28 GMT
etag
W/"6542941c-14d8"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
bFgYjnGsTAXYTmEvxlCNmgSfpzwa0IWzYZngQvBpUSuGoAMN8obChQ==
expires
Wed, 22 Nov 2023 17:54:25 GMT
endpoints.min.css
endpts.com/wp-content/plugins/endpoints/assets/css/
24 KB
7 KB
Stylesheet
General
Full URL
https://endpts.com/wp-content/plugins/endpoints/assets/css/endpoints.min.css?ver=259665458
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
82677c6bca6cbe1793f891864a61dc9843160336ca62b99640c0452e3ef8ea00
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 17:54:27 GMT
content-encoding
gzip
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
171154
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:32 GMT
etag
W/"655503bc-60e4"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
text/css
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
B4hpaUbscjdlAnO8mhZKNBOICEAAdo_Xx_2l4x3GgpuLS2i7S2-LoA==
expires
Wed, 22 Nov 2023 17:54:27 GMT
js
www.googletagmanager.com/gtag/
269 KB
90 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-9QWNX9N9E5
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
5dc7a00435a4acd1aec07b6caafe35a2ed35cd28f8c1ad34a334f9f3ff0572fc
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
91673
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Fri, 17 Nov 2023 17:27:02 GMT
image-3.jpg
endpts.com/wp-content/uploads/2023/11/
229 KB
230 KB
Image
General
Full URL
https://endpts.com/wp-content/uploads/2023/11/image-3.jpg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
891bdfb47b13fe75c3ff86a1d7a7998f867beaafbaaf0a31c23d6760f1ed0344
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Mon, 13 Nov 2023 11:05:30 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
368491
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
234243
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Tue, 07 Nov 2023 21:12:01 GMT
etag
"654aa821-39303"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
9rVkLl37MrDWjo1cqV7P-2YI1NDrw9_0uHWCbhR1gNC9wkXCtR5gSQ==
expires
Mon, 20 Nov 2023 11:05:30 GMT
image-1.jpg
endpts.com/wp-content/uploads/2023/11/
158 KB
159 KB
Image
General
Full URL
https://endpts.com/wp-content/uploads/2023/11/image-1.jpg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
90dad304078f2210edf1c1fc3cff9e85afe07c0e004c86be51d6699a2458899c
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Mon, 13 Nov 2023 11:05:34 GMT
via
1.1 524f30fc42ae138c5b6185cefbec064a.cloudfront.net (CloudFront)
x-content-type-options
nosniff
strict-transport-security
max-age=2592000; includeSubDomains; preload
x-amz-cf-pop
CDG50-C1
age
368487
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
161609
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Tue, 07 Nov 2023 21:11:19 GMT
etag
"654aa7f7-27749"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
P6kuZ8OmFXe12tG-sFMnJoEGBomoXYxcSFv0fakz-Ia0A0FVTTKxpA==
expires
Mon, 20 Nov 2023 11:05:34 GMT
image-5.jpg
endpts.com/wp-content/uploads/2023/11/
177 KB
178 KB
Image
General
Full URL
https://endpts.com/wp-content/uploads/2023/11/image-5.jpg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
8d2f944af971bb38d6cc789a8200f8e3a3db30934e43f3e98033ee0f3c200855
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Mon, 13 Nov 2023 11:05:29 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
368493
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
181581
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Tue, 07 Nov 2023 21:13:01 GMT
etag
"654aa85d-2c54d"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
awtUyjre2ckiTY-ZuZqme0vdGQExAQfEDdVupu2I4pSM0C2IVIzk_g==
expires
Mon, 20 Nov 2023 11:05:29 GMT
ft_specialist.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ft/
3 KB
3 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ft/ft_specialist.svg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
957d55d93f45911759330a897fd902c287bd90968bb01ea55777ed85a4c79bd1
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:51 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171131
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
2576
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-a10"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
x5-H9AnqdyZ4gjabAvpJcIE7ThD8VdzeF8H6Ywl0_1QmntwPwKvFxA==
expires
Wed, 22 Nov 2023 17:54:51 GMT
ft_service.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ft/
6 KB
6 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ft/ft_service.svg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
501574417d204089a9f47f632e5d836b6873ab6338c4f5584db6319376742870
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:51 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171131
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
6069
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-17b5"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
wzSS8QIb3n9kVm9aC-4zQtoMAhlxm3-LCqvAoxZXZTdLHTnpg8gIbA==
expires
Wed, 22 Nov 2023 17:54:51 GMT
epn_logo.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
3 KB
3 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
8f78ecde454d24cfa5cda6f3c16346e9741ac104a6abfa01dd81dc03692f6887
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:51 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171131
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
2777
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-ad9"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
ZTWYETyVzrBGFVhlfEbUQyLRB-7uJMrAiTUDtq_GuEls0zpJmeEBuQ==
expires
Wed, 22 Nov 2023 17:54:51 GMT
jquery.min.js
endpts.com/wp-content/themes/endpoints-rakia/assets/js/
88 KB
31 KB
Script
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/jquery.min.js?ver=3.6.1
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
a3cf00c109d907e543bc4f6dbc85eb31068f94515251347e9e57509b52ee3d74
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:28 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
171154
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
W/"65550334-15e40"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
iadF2UnD4jpwN0bbdt3P7_SPuPiyB8kH4X_YnPEuCcRpJv7tVOU6YQ==
expires
Wed, 22 Nov 2023 17:54:28 GMT
ca_animator.min.js
endpts.com/wp-content/themes/endpoints-rakia/assets/js/
1 KB
1 KB
Script
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/ca_animator.min.js?ver=361844066
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
dfb12b86e80fdae177b4cd2997199291924e4ef8a0e34fa5899afc694a55fd14
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:29 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
171153
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:43 GMT
etag
W/"655503c7-5ff"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
0wIyOiL1GhBD2NYQeosKDEAEKKfO3mGBMPmsougVyVki0vnpGSi26A==
expires
Wed, 22 Nov 2023 17:54:29 GMT
client.min.js
api.stats.endpts.com/assets/
2 KB
2 KB
Script
General
Full URL
https://api.stats.endpts.com/assets/client.min.js?ver=259665458
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
50.17.168.97 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-50-17-168-97.compute-1.amazonaws.com
Software
/
Resource Hash
48ccd6f4d29e4b54c7a3fca9a276863f18006feadd5aa8f53ea0fbd7d5e9c652

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
last-modified
Wed, 15 Nov 2023 09:26:49 GMT
etag
"65548ed9-615"
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public
accept-ranges
bytes
content-length
1557
expires
Fri, 24 Nov 2023 17:27:02 GMT
tUtils.min.js
endpts.com/wp-content/plugins/endpoints/assets/js/
11 KB
4 KB
Script
General
Full URL
https://endpts.com/wp-content/plugins/endpoints/assets/js/tUtils.min.js?ver=259665458
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
e8aa659481614b0856c24ad94dbf0696eaab934d0ed64b5b68a1f5b23024658c
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:25 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
171157
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:37 GMT
etag
W/"655503c1-2d70"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
dlCHZw7_i4NgsX08ku0bGcaeVwOsNysGyv_KKPtqvAp27L9uU2eIIA==
expires
Wed, 22 Nov 2023 17:54:25 GMT
bootstrap.bundle.min.js
endpts.com/wp-content/themes/endpoints-rakia/assets/js/
81 KB
22 KB
Script
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/bootstrap.bundle.min.js?ver=4.6.2
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
19126b874a32753d42c12dfa6c17892bfd93820a5a5100ba1b34da4d07599b49
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:32 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
171150
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
W/"65550334-145b0"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
VuigqikjbgLsdmzcUOCRUUQEM47S9Gh7h8TL17NDuLD8Ll_1PQhamQ==
expires
Wed, 22 Nov 2023 17:54:31 GMT
script.min.js
endpts.com/wp-content/themes/endpoints-rakia/assets/js/
18 KB
4 KB
Script
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/script.min.js?ver=361844066
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
f5dbea1b2dd296a3fab34d5f501219ceb7b55f8c60b69a9a0313a4a4f477b4c1
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:32 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
171150
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:43 GMT
etag
W/"655503c7-46fb"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
n8G_-BO_HTv_ZRQop9zztVeg1IP5f5NA85K_B6BHEj7YU4oJ12UYLQ==
expires
Wed, 22 Nov 2023 17:54:32 GMT
endpoints.min.js
endpts.com/wp-content/plugins/endpoints/assets/js/
57 KB
12 KB
Script
General
Full URL
https://endpts.com/wp-content/plugins/endpoints/assets/js/endpoints.min.js?ver=259665458
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
ddd41af307a619c1492e46cfb172361857fe471c557a017d7252b959e4bb3013
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:33 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
171149
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:45:34 GMT
etag
W/"655503be-e594"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
rdehGXR-Cigtb487BijjDi4roJG1YpkcEragamtS54UCjY0PU12bnA==
expires
Wed, 22 Nov 2023 17:54:33 GMT
chartbeat.js
static.chartbeat.com/js/
37 KB
15 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat.js
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2050:d600:18:1fcd:353:c61 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
2241d391f10f461a915b6ef47bc0c8103bf0e7289aff47e1bcfed5ff2a84d119

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 16:00:08 GMT
content-encoding
gzip
via
1.1 7da8d24daaa6257fb28a90cd4a3bbe5c.cloudfront.net (CloudFront)
last-modified
Thu, 16 Nov 2023 01:59:58 GMT
server
nginx
x-amz-cf-pop
BUD50-C1
age
5214
etag
W/"6555779e-94a1"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
cache-control
max-age=7200
cross-origin-resource-policy
cross-origin
x-amz-cf-id
FXWSawGYlZSi85yJ3R_tIBBksDd1FCfqS2LPxr5sQFLQQJeC6j5s1A==
expires
Fri, 17 Nov 2023 18:00:08 GMT
insight.min.js
snap.licdn.com/li.lms-analytics/
12 KB
4 KB
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:3500:16::215:149b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
f88f89a0cead9c36ddbe19508f32f64bd91e94e92b6006dd575e8d0deb317d7f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 15 Nov 2023 09:07:27 GMT
x-cdn
AKAM
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
application/javascript;charset=utf-8
cache-control
max-age=39275
accept-ranges
bytes
content-length
3840
fkTidDPj96U
www.youtube.com/embed/ Frame EB2B
90 KB
40 KB
Document
General
Full URL
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
9a712a8b872fbe201fe16cc043ce4b629e368e1fe32818bc8145b1cfaa5d5157
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
br
content-security-policy-report-only
require-trusted-types-for 'script';report-uri /cspreport
content-type
text/html; charset=utf-8
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
cross-origin-resource-policy
cross-origin
date
Fri, 17 Nov 2023 17:27:02 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma
no-cache
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server
ESF
strict-transport-security
max-age=31536000
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options
nosniff
x-xss-protection
0
search.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
450 B
843 B
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/search.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
e6b669d5b7fff5655a7e65e4bc93f779d3a991f7f1f12a1c21094e0db48603f1
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
170996
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
450
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-1c2"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
lhW5E-yTrY6rfzgoEAidPcv2BKx_GJPihjET5hmE5vz20dDkQjgrtQ==
expires
Wed, 22 Nov 2023 17:57:06 GMT
Concourse_T4_Regular.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
24 KB
25 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_T4_Regular.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/fonts.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
e19256fbb2f570bba4b3b706bffca86d75653fdbaee820f6c5c7cbce26d4752e
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/fonts.min.css?ver=361844066
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:57:06 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
170996
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
24740
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-60a4"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
ruiAuv4YqO84KHKll-mtEeD_YZ6fzPJbSaSYXx818JySbjKQfj-Y9w==
expires
Wed, 29 Nov 2023 17:57:06 GMT
social-share.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
324 B
718 B
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/social-share.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
05838d9514f0b5c0ac22020c163f8d94c6ea2d9335da6a85609ecc546598522b
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:25 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171157
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
324
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-144"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
p2RA9KjgykfIkKFY6FqdqaTCHPp6agPt32Ltp6n5-RYK0gcUXhHI7g==
expires
Wed, 22 Nov 2023 17:54:25 GMT
social-linkedin.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
560 B
953 B
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/social-linkedin.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
161451f4dcd867504c46d414dbcbcf4bf4e53b8b80c6ced64932d5e77750438c
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:25 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171157
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
560
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-230"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
sPHQPS3QBixbUbjd986oo08A6ShiIKatsvobpZzkVX7MwSAW0sEnTA==
expires
Wed, 22 Nov 2023 17:54:25 GMT
social-twitter.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
689 B
1 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/social-twitter.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
6de72016b4fd3dc90b7c091f5bebb5af2039f093c0c27dfa3ee8b10d17f1ea6c
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:25 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171157
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
689
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-2b1"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
OpR5oafpJrZjNw1cnYdwFDbq3MVZ1JYXi8a26IJgSQjfqnU2sdL1Dg==
expires
Wed, 22 Nov 2023 17:54:25 GMT
Author-Image-FSP-1.png
endpts.com/wp-content/uploads/2023/11/
18 KB
18 KB
Image
General
Full URL
https://endpts.com/wp-content/uploads/2023/11/Author-Image-FSP-1.png
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
88d6c8a9c3ecfeddb00065d708d2f85f8e458e1e6afa045c8a813ecb717a4bea
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Mon, 13 Nov 2023 17:16:45 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
346217
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
18031
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Tue, 07 Nov 2023 20:51:13 GMT
etag
"654aa341-466f"
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
EJ4GJUMm4bktDDB_PGZHVpu0bYfZZ9Af8DF9zskrHC7SnhHo5GuS5A==
expires
Mon, 20 Nov 2023 17:16:45 GMT
ux_envelope.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
708 B
1 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ux_envelope.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
d4be21edc91dacc4c2d70e0cee7847bf4542c14d1003020c4f3354dca8777ab0
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:26 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171156
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
708
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-2c4"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
B6f0-ApisBiTFSPvoOtV07wKKg4HEG0Zsr4Z8fE-41b9VeyFPxUIRA==
expires
Wed, 22 Nov 2023 17:54:26 GMT
ux_web.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
999 B
1 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ux_web.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
46d942eeadc92c24e5536c617dc6ec852e941e5d67f2e84546717d850bbec920
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 18:37:36 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
168566
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
999
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-3e7"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
OU1PjuTiI4ibLKbLVbrweKUXiIflEsgDxPs5RkFK-21t8M74KVRuUA==
expires
Wed, 22 Nov 2023 18:37:36 GMT
footer-twitter.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
1000 B
1 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/footer-twitter.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
b1238f9e3d9f65ece284fe998881a93f46e892c28086c941303c26bd88a8923b
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:57:07 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
1000
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-3e8"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
50Cc_mT86Hq_bTGnM-YLV3gqZDOhU2CkDnd44m_H-Xf6bQBby3ZSew==
expires
Wed, 22 Nov 2023 17:57:07 GMT
footer-linkedin.svg
endpts.com/wp-content/themes/endpoints-rakia/assets/svg/
820 B
1 KB
Image
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/footer-linkedin.svg
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
34a83684584edc961260bc36bec5ada1a63310637e43e2b0ea3239bc07f6fae3
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=361844066
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:57:07 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
170995
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
820
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-334"
x-frame-options
SAMEORIGIN
content-type
image/svg+xml
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
_2d26LRRfG9B4BHzlk5X3KpyTNOozkvaNmcJwLvDZ6YEYvFk4IsGjg==
expires
Wed, 22 Nov 2023 17:57:07 GMT
IvarHeadline_Bold.woff2
endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/
32 KB
33 KB
Font
General
Full URL
https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarHeadline_Bold.woff2
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/fonts.min.css?ver=361844066
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
d57ed0f9e905678c35d1c3a3c222e655c468b8b4cba463774c3f23a01edda392
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/fonts.min.css?ver=361844066
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 17:54:52 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
171130
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
33064
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 17:43:16 GMT
etag
"65550334-8128"
x-frame-options
SAMEORIGIN
content-type
application/octet-stream
cache-control
max-age=1209600, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
8qyYEpeO9IfeMK2AKWrulQv3bvU5qngpdrnIzaUDjwG3vWc6pxQL4Q==
expires
Wed, 29 Nov 2023 17:54:52 GMT
Anchor-Image-FSP-1.jpg
endpts.com/wp-content/uploads/2023/11/
81 KB
81 KB
Image
General
Full URL
https://endpts.com/wp-content/uploads/2023/11/Anchor-Image-FSP-1.jpg
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
9d8be71d6126ef450aa374ae6917aec5bb24da43ba52e4bd9827d7ef2f6eec80
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Mon, 13 Nov 2023 11:11:54 GMT
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-content-type-options
nosniff
x-amz-cf-pop
CDG50-C1
age
368108
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
content-length
82450
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Tue, 07 Nov 2023 20:54:40 GMT
etag
"654aa410-14212"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=604800, public, public, max-age=2592000
accept-ranges
bytes
x-amz-cf-id
sxP5buskwqL9aYjWAxrLMgmaeogy-UgBK7Py21pk7p86DvBXyvXJIA==
expires
Mon, 20 Nov 2023 11:11:54 GMT
d0ffa465-1832-4811-9b52-b189c2b2a18e
https://endpts.com/
1 KB
0
Other
General
Full URL
blob:https://endpts.com/d0ffa465-1832-4811-9b52-b189c2b2a18e
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
453cb806084fdabec32e286af2e88899f79022125c2527afffbec507975d2c22

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

Content-Length
1245
Content-Type
text/javascript
collect
region1.analytics.google.com/g/
0
250 B
Ping
General
Full URL
https://region1.analytics.google.com/g/collect?v=2&tid=G-9QWNX9N9E5&gtm=45je3b81v877501060&_p=1700242022082&_gaz=1&gcd=11l1l1l1l1&dma_cps=sypham&dma=1&cid=1344095111.1700242022&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_s=1&sid=1700242022&sct=1&seg=0&dl=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F%3Futm_medium%3Demail%26utm_campaign%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%26utm_content%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%2BCID_7bc57866ee1d8dfbb6c7e8af351448d3%26utm_source%3DENDPOINTS%2520emails%26utm_term%3DClinshyishycal%2520Studshyies%2520In%2520Japan%2520Toshyday%2520Anshyothshyer%2520Look%2520At%2520The%2520Worlds%2520Secshyond-Largest%2520Preshyscripshytion%2520Drug%2520Marshyket%2520In%2520A%2520Post-Panshydemshyic%2520World&dt=Clinical%20Studies%20In%20Japan%20Today%3A%20Another%20Look%20At%20The%20World%E2%80%99s%20Second-Largest%20Prescription%20Drug%20Market%20In%20A%20Post-Pandemic%20World%20%E2%80%93%20Endpoints%20News&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&up.user_type=Guest&tfd=1327
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-9QWNX9N9E5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 17 Nov 2023 17:27:02 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://endpts.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
241 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-9QWNX9N9E5&cid=1344095111.1700242022&gtm=45je3b81v877501060&aip=1&dma=1&dma_cps=sypham&gcd=11l1l1l1l1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-9QWNX9N9E5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c00::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 17 Nov 2023 17:27:02 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://endpts.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
408 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-9QWNX9N9E5&cid=1344095111.1700242022&gtm=45je3b81v877501060&aip=1&dma=1&dma_cps=sypham&gcd=11l1l1l1l1&z=1111225729
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 17 Nov 2023 17:27:02 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
www-player.css
www.youtube.com/s/player/190c935f/ Frame EB2B
378 KB
48 KB
Stylesheet
General
Full URL
https://www.youtube.com/s/player/190c935f/www-player.css
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f27def9acb53f27287b73f15b98b424b2227894d98f2a0c238f3e5e3b2843af2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:07:58 GMT
content-encoding
br
x-content-type-options
nosniff
age
1144
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
48795
x-xss-protection
0
last-modified
Wed, 15 Nov 2023 02:47:17 GMT
server
sffe
vary
Accept-Encoding, Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
text/css
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Sat, 16 Nov 2024 17:07:58 GMT
cspreport
www.youtube.com/ Frame EB2B
0
210 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
141 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
132 B
Other
General
Full URL
https://www.youtube.com/cspreport
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/csp-report

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
strict-transport-security
max-age=31536000
x-content-type-options
nosniff
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
server
ESF
x-frame-options
SAMEORIGIN
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.youtube.com
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
origin-trial
AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
expires
Mon, 01 Jan 1990 00:00:00 GMT
cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

cspreport
www.youtube.com/ Frame EB2B
0
0

KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame EB2B
15 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/
Origin
https://www.youtube.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Sun, 12 Nov 2023 06:30:11 GMT
x-content-type-options
nosniff
age
471411
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15344
x-xss-protection
0
last-modified
Mon, 16 Oct 2017 17:32:55 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 11 Nov 2024 06:30:11 GMT
KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v18/ Frame EB2B
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v18/KFOlCnqEu92Fr1MmEU9fBBc4.woff2
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.youtube.com/
Origin
https://www.youtube.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 21:01:27 GMT
x-content-type-options
nosniff
age
159935
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15552
x-xss-protection
0
last-modified
Mon, 16 Oct 2017 17:33:02 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 14 Nov 2024 21:01:27 GMT
embed.js
www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/ Frame EB2B
57 KB
18 KB
Script
General
Full URL
https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/embed.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
65030c1bb33a7d3b00574b46d56c6fefc6e4430bf4f2b23de425078585c0ec50
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 16:27:19 GMT
content-encoding
br
x-content-type-options
nosniff
age
3583
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
17875
x-xss-protection
0
last-modified
Wed, 15 Nov 2023 02:47:17 GMT
server
sffe
vary
Accept-Encoding, Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Sat, 16 Nov 2024 16:27:19 GMT
www-embed-player.js
www.youtube.com/s/player/190c935f/www-embed-player.vflset/ Frame EB2B
322 KB
96 KB
Script
General
Full URL
https://www.youtube.com/s/player/190c935f/www-embed-player.vflset/www-embed-player.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5b794c3bb91599f949ed26b4cd85a2a068629b8770aee5be43d6d352f676e13e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 16:10:09 GMT
content-encoding
br
x-content-type-options
nosniff
age
4613
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
98594
x-xss-protection
0
last-modified
Wed, 15 Nov 2023 02:47:17 GMT
server
sffe
vary
Accept-Encoding, Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Sat, 16 Nov 2024 16:10:09 GMT
base.js
www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/ Frame EB2B
2 MB
764 KB
Script
General
Full URL
https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/base.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
65d9d35ac0df81d0440f783d9ff8a084b17c6aa133228424f468eb240c085a33
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 08:33:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
204828
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
781301
x-xss-protection
0
last-modified
Wed, 15 Nov 2023 02:47:17 GMT
server
sffe
vary
Accept-Encoding, Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Thu, 14 Nov 2024 08:33:14 GMT
insight.beta.min.js
snap.licdn.com/li.lms-analytics/
42 KB
16 KB
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.beta.min.js
Requested by
Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:3500:16::215:149b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
1c3a7ff59b70e536b9fa30bd51521d75425c898aeacce42fa1b549fc5b5f7220
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

x-edgeconnect-origin-mex-latency
653
date
Fri, 17 Nov 2023 17:27:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 17 Nov 2023 13:15:29 GMT
x-cdn
AKAM
x-edgeconnect-midmile-rtt
1
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
application/javascript;charset=utf-8
cache-control
max-age=71318
accept-ranges
bytes
content-length
15623
collect
px4.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=2273916%2C5136028&time=1700242022405&url=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest...
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=2273916%2C5136028&time=1700242022405&url=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-larges...
0
266 B
Image
General
Full URL
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=2273916%2C5136028&time=1700242022405&url=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F%3Futm_medium%3Demail%26utm_campaign%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%26utm_content%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%2BCID_7bc57866ee1d8dfbb6c7e8af351448d3%26utm_source%3DENDPOINTS%2520emails%26utm_term%3DClinshyishycal%2520Studshyies%2520In%2520Japan%2520Toshyday%2520Anshyothshyer%2520Look%2520At%2520The%2520Worlds%2520Secshyond-Largest%2520Preshyscripshytion%2520Drug%2520Marshyket%2520In%2520A%2520Post-Panshydemshyic%2520World&e_ipv6=AQKNjzrczxHfAgAAAYveUmCRF2Ixsy1dE3utCKN4HVb60nhVOaNZ1kEDrXXP0IvCIvQU6ReTVXsj
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Server
13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 151B28CBAE9C41B5A5687816C15D9933 Ref B: DUS30EDGE0911 Ref C: 2023-11-17T17:27:02Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
content-type
application/javascript
x-li-fabric
prod-ltx1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYKXHHNnYRyeAyRJtORkw==

Redirect headers

date
Fri, 17 Nov 2023 17:27:02 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 60DD7E10D7D54781B30257FE6F4BC923 Ref B: FRAEDGE1215 Ref C: 2023-11-17T17:27:02Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
location
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=2273916%2C5136028&time=1700242022405&url=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F%3Futm_medium%3Demail%26utm_campaign%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%26utm_content%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%2BCID_7bc57866ee1d8dfbb6c7e8af351448d3%26utm_source%3DENDPOINTS%2520emails%26utm_term%3DClinshyishycal%2520Studshyies%2520In%2520Japan%2520Toshyday%2520Anshyothshyer%2520Look%2520At%2520The%2520Worlds%2520Secshyond-Largest%2520Preshyscripshytion%2520Drug%2520Marshyket%2520In%2520A%2520Post-Panshydemshyic%2520World&e_ipv6=AQKNjzrczxHfAgAAAYveUmCRF2Ixsy1dE3utCKN4HVb60nhVOaNZ1kEDrXXP0IvCIvQU6ReTVXsj
x-li-proto
http/2
content-length
0
x-li-uuid
AAYKXHHJFRhi/yla1q0Piw==
mixpanel-2-latest.min.js
cdn.mxpnl.com/libs/
52 KB
18 KB
Script
General
Full URL
https://cdn.mxpnl.com/libs/mixpanel-2-latest.min.js
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/plugins/endpoints/assets/js/tUtils.min.js?ver=259665458
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:1901:0:498c:: Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
UploadServer /
Resource Hash
acb1221313fbb4d27f785ffd7a9ade0f7f44c37567ce1abf6aff7c399a7992d4

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:21:42 GMT
content-encoding
gzip
age
320
x-guploader-uploadid
ABPtcPokDcZOHpEMXO8ZLz7cDVqwdRQLzr9slmkOUfJnwJYgJqIF_x6K2Y3R2rbtdOzwywIe3mN4tDKY
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18139
last-modified
Tue, 14 Nov 2023 19:54:10 GMT
server
UploadServer
etag
"dff66d0b72bdc18a02be56412d5ef8c4"
vary
Accept-Encoding
x-goog-generation
1699991650202934
x-goog-hash
crc32c=VW26dg==, md5=3/ZtC3K9wYoCvlZBLV74xA==
access-control-allow-origin
*
content-type
text/javascript
cache-control
public,max-age=600
x-goog-stored-content-length
18139
accept-ranges
bytes
expires
Fri, 17 Nov 2023 17:31:42 GMT
wp-emoji-release.min.js
endpts.com/wp-includes/js/
18 KB
5 KB
Script
General
Full URL
https://endpts.com/wp-includes/js/wp-emoji-release.min.js?ver=6.4.1
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
99.86.91.113 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-91-113.cdg50.r.cloudfront.net
Software
/
Resource Hash
4f79a89d16a5f717110fe080c0bf90b7e05ff95a4c4983f64d33110bf5f9c230
Security Headers
Name Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

strict-transport-security
max-age=2592000; includeSubDomains; preload
date
Wed, 15 Nov 2023 09:46:11 GMT
x-content-type-options
nosniff
content-encoding
gzip
x-amz-cf-pop
CDG50-C1
age
200451
via
1.1 e225339d299ad31ad0818dbdb8c65826.cloudfront.net (CloudFront)
x-cache
Hit from cloudfront
alt-svc
h3=":443"; ma=86400
x-xss-protection
1; mode=block
referrer-policy
same-origin
last-modified
Wed, 15 Nov 2023 09:44:10 GMT
etag
W/"655492ea-4904"
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800, public, public, max-age=2592000
x-amz-cf-id
9DHzHfEm-PR3UuK41ajTBhJerKgOuSznh-yOgdL_jWkrvDX_d95qog==
expires
Wed, 22 Nov 2023 09:46:11 GMT
ping
ping.chartbeat.net/
43 B
201 B
Image
General
Full URL
https://ping.chartbeat.net/ping?h=endpts.com&p=%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F&u=BCjPDeDtRhjSC_rd4W&d=endpts.com&g=67111&g0=No%20Section&g1=CMIC%20Group&g4=Sponsored%20Post&n=1&f=00001&c=0&x=0&m=0&y=8289&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&PA=https%3A%2F%2Fendpts.com%2Fsp%2Fclinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world%2F%3Futm_medium%3Demail%26utm_campaign%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%26utm_content%3D550%2520-%2520Gileads%2520Kite%2520deepens%2520CAR-T%2520ties%2520with%2520Arcellx%2520Alkermes%2520seeds%2520oncology%2520spinout%2520with%2520275M%2520IL-2%2520drugs%2520Basic%2BCID_7bc57866ee1d8dfbb6c7e8af351448d3%26utm_source%3DENDPOINTS%2520emails%26utm_term%3DClinshyishycal%2520Studshyies%2520In%2520Japan%2520Toshyday%2520Anshyothshyer%2520Look%2520At%2520The%2520Worlds%2520Secshyond-Largest%2520Preshyscripshytion%2520Drug%2520Marshyket%2520In%2520A%2520Post-Panshydemshyic%2520World&b=1650&_c=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&_m=email&_x=ENDPOINTS%20emails&_y=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic%20CID_7bc57866ee1d8dfbb6c7e8af351448d3&_z=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World&t=DA2LJMBNMbKs6OwJRDTEPapkq5PX&V=141&i=Clinical%20Studies%20In%20Japan%20Today%3A%20Another%20Look%20At%20The%20World%E2%80%99s%20Second-Largest%20Prescription%20Drug%20Market%20In%20A%20Post-Pandemic%20World&tz=-60&_acct=anon&sn=1&sv=CHiY1XBrEvvGDJFSJMBzXS2BDL2gWV&sd=1&im=066b0f7f&_
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.4.243.120 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-4-243-120.compute-1.amazonaws.com
Software
/
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Fri, 17 Nov 2023 17:27:02 GMT
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-length
43
expires
0
id
googleads.g.doubleclick.net/pagead/ Frame EB2B
Redirect Chain
  • https://googleads.g.doubleclick.net/pagead/id
  • https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
100 B
242 B
XHR
General
Full URL
https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
37d00b7e40c6a1056b4185979700a922e4027515658f4e07688ecda6c34fc051
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
120
x-xss-protection
0
pragma
no-cache
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date
Fri, 17 Nov 2023 17:27:02 GMT
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
pragma
no-cache
server
cafe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
access-control-allow-origin
https://www.youtube.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ad_status.js
static.doubleclick.net/instream/ Frame EB2B
29 B
495 B
Script
General
Full URL
https://static.doubleclick.net/instream/ad_status.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/www-embed-player.vflset/www-embed-player.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:813::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
eed0dc1fdb5d97ed188ae16fd5e1024a5bb744af47340346be2146300a6c54b9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:17:38 GMT
x-content-type-options
nosniff
age
564
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
29
x-xss-protection
0
last-modified
Thu, 12 Dec 2013 23:40:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=900
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 17 Nov 2023 17:32:38 GMT
Create
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame
0
0
Preflight
General
Full URL
https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/Create
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type,x-goog-api-key,x-user-agent
Access-Control-Request-Method
POST
Origin
https://www.youtube.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type,x-goog-api-key,x-user-agent
access-control-allow-methods
DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin
https://www.youtube.com
access-control-max-age
3600
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
content-type
text/html
date
Fri, 17 Nov 2023 17:27:02 GMT
server
ESF
vary
origin referer x-origin
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-xss-protection
0
Create
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame EB2B
70 KB
32 KB
XHR
General
Full URL
https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/Create
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/base.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:803::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
4ca25192305b644dba7934b82e5dcdd6cd1e670e25a7a169497e8e7c9493c7af
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

X-User-Agent
grpc-web-javascript/0.1
Referer
https://www.youtube.com/
X-Goog-Api-Key
AIzaSyDyT5W0Jh49F30Pqqtyfdf7pDLFKLJoAnw
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/json+protobuf

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
ESF
vary
Origin, X-Origin, Referer
x-frame-options
SAMEORIGIN
content-type
application/json+protobuf; charset=UTF-8
access-control-allow-origin
https://www.youtube.com
access-control-expose-headers
vary,vary,vary,content-encoding,date,server,content-length
cache-control
private
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
32843
x-xss-protection
0
remote.js
www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/ Frame EB2B
116 KB
33 KB
Script
General
Full URL
https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/remote.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/base.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
266f10bcd8445642b63ba1729f7ef7c99816684782ccf290eb924d3c675e5072
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Wed, 15 Nov 2023 21:53:32 GMT
content-encoding
br
x-content-type-options
nosniff
age
156810
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
33664
x-xss-protection
0
last-modified
Wed, 15 Nov 2023 02:47:17 GMT
server
sffe
vary
Accept-Encoding, Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Thu, 14 Nov 2024 21:53:32 GMT
iPEf94t7kg41AT9t4roGKH7lRPlVKxurQ2Q3DUZ2d_o.js
www.google.com/js/th/ Frame EB2B
39 KB
15 KB
Script
General
Full URL
https://www.google.com/js/th/iPEf94t7kg41AT9t4roGKH7lRPlVKxurQ2Q3DUZ2d_o.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/base.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88f11ff78b7b920e35013f6de2ba06287ee544f9552b1bab4364370d467677fa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Thu, 16 Nov 2023 14:09:13 GMT
content-encoding
br
x-content-type-options
nosniff
age
98269
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15286
x-xss-protection
0
last-modified
Mon, 06 Nov 2023 17:00:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Fri, 15 Nov 2024 14:09:13 GMT
sddefault.jpg
i.ytimg.com/vi/fkTidDPj96U/ Frame EB2B
14 KB
14 KB
Image
General
Full URL
https://i.ytimg.com/vi/fkTidDPj96U/sddefault.jpg?sqp=-oaymwEmCIAFEOAD8quKqQMa8AEB-AH-CYAC0AWKAgwIABABGHIgVChEMA8=&rs=AOn4CLDgEwtU3WLIXqP9vGoHI--yI8IO5w
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2016 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
53877dbedb9bc7ccc8089e2c3666188d1489decf87d4d22ccc543b90b1119585
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 16:32:44 GMT
x-content-type-options
nosniff
age
3258
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
14336
x-xss-protection
0
server
sffe
etag
"1664501506"
vary
Origin
report-to
{"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type
image/jpeg
cache-control
public, max-age=7200
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="youtube"
expires
Fri, 17 Nov 2023 18:32:44 GMT
truncated
/ Frame EB2B
175 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
67ea46bc3d15351067faccb3613bd833dd3f15137a4b4a09f2e873fd41d024d2

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

Content-Type
image/png
APkrFKYh03qp7eiglsAti4avM_I-aEWZVwnOIgoAB65Prw=s68-c-k-c0x00ffffff-no-rj
yt3.ggpht.com/ytc/ Frame EB2B
2 KB
2 KB
Image
General
Full URL
https://yt3.ggpht.com/ytc/APkrFKYh03qp7eiglsAti4avM_I-aEWZVwnOIgoAB65Prw=s68-c-k-c0x00ffffff-no-rj
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
fife /
Resource Hash
e3a19360990c170260fa8ae6b7fb189c73eddf28035c0f882c23f7f285b0ab6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
x-content-type-options
nosniff
age
0
content-disposition
inline;filename="unnamed.jpg"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2178
x-xss-protection
0
server
fife
etag
"v104"
vary
Origin
content-type
image/jpeg
access-control-allow-origin
*
access-control-expose-headers
Content-Length
cache-control
public, max-age=86400, no-transform
timing-allow-origin
*
expires
Sat, 18 Nov 2023 17:27:02 GMT
cast_sender.js
www.gstatic.com/cv/js/sender/v1/ Frame EB2B
4 KB
2 KB
Script
General
Full URL
https://www.gstatic.com/cv/js/sender/v1/cast_sender.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/base.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ee147e859ad0f09aa50367974e38ab53e7c7054c4a51d400a7f45b0eb251454f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/cloudview
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
2007
x-xss-protection
0
last-modified
Tue, 16 Feb 2021 23:57:06 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="cloudview"
vary
Accept-Encoding
report-to
{"group":"cloudview","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/cloudview"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Fri, 17 Nov 2023 17:27:02 GMT
cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

cspreport
www.youtube.com/ Frame 738D
0
0

generate_204
www.youtube.com/ Frame EB2B
0
10 B
Image
General
Full URL
https://www.youtube.com/generate_204?kgzcNw
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

cspreport
www.youtube.com/ Frame 0D16
0
0

GenerateIT
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame
0
0
Preflight
General
Full URL
https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/GenerateIT
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type,x-goog-api-key,x-user-agent
Access-Control-Request-Method
POST
Origin
https://www.youtube.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type,x-goog-api-key,x-user-agent
access-control-allow-methods
DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin
https://www.youtube.com
access-control-max-age
3600
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
content-type
text/html
date
Fri, 17 Nov 2023 17:27:03 GMT
server
ESF
vary
origin referer x-origin
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-xss-protection
0
cspreport
www.youtube.com/ Frame 0D16
0
0

GenerateIT
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame EB2B
90 B
134 B
XHR
General
Full URL
https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/GenerateIT
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/player_ias.vflset/de_DE/base.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:803::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
310e079c56f9661a597fe09e0443ee784b1115e5b87484769f9d5b96100e016a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

X-User-Agent
grpc-web-javascript/0.1
Referer
https://www.youtube.com/
X-Goog-Api-Key
AIzaSyDyT5W0Jh49F30Pqqtyfdf7pDLFKLJoAnw
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/json+protobuf

Response headers

date
Fri, 17 Nov 2023 17:27:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
ESF
vary
Origin, X-Origin, Referer
x-frame-options
SAMEORIGIN
content-type
application/json+protobuf; charset=UTF-8
access-control-allow-origin
https://www.youtube.com
access-control-expose-headers
vary,vary,vary,content-encoding,date,server,content-length
cache-control
private
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
110
x-xss-protection
0
/
px.ads.linkedin.com/wa/
0
190 B
XHR
General
Full URL
https://px.ads.linkedin.com/wa/
Requested by
Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.beta.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
*
Referer
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Fri, 17 Nov 2023 17:27:02 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 9215791298804020B1FC870E18765A6F Ref B: FRAEDGE1215 Ref C: 2023-11-17T17:27:03Z
linkedin-action
1
vary
Origin
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
access-control-allow-origin
https://endpts.com
x-li-proto
http/2
access-control-allow-credentials
true
x-li-uuid
AAYKXHHShH+fj3vke5paqA==
cast_sender.js
www.gstatic.com/eureka/clank/119/ Frame EB2B
50 KB
15 KB
Script
General
Full URL
https://www.gstatic.com/eureka/clank/119/cast_sender.js
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/cv/js/sender/v1/cast_sender.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f4d5deb4709cebcb8d869180a1db81fab7c54f99dc2e72dab8b3db15eb76e660
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.youtube.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

date
Thu, 16 Nov 2023 19:01:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
80758
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/cloudview-release
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
14705
x-xss-protection
0
last-modified
Mon, 02 Oct 2023 15:08:53 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="cloudview-release"
vary
Accept-Encoding
report-to
{"group":"cloudview-release","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/cloudview-release"}]}
content-type
text/javascript
cache-control
public, max-age=86400
accept-ranges
bytes
expires
Fri, 17 Nov 2023 19:01:05 GMT
nr-rum-1.248.0.min.js
js-agent.newrelic.com/
44 KB
16 KB
Script
General
Full URL
https://js-agent.newrelic.com/nr-rum-1.248.0.min.js
Requested by
Host: endpts.com
URL: https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/?utm_medium=email&utm_campaign=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic&utm_content=550%20-%20Gileads%20Kite%20deepens%20CAR-T%20ties%20with%20Arcellx%20Alkermes%20seeds%20oncology%20spinout%20with%20275M%20IL-2%20drugs%20Basic+CID_7bc57866ee1d8dfbb6c7e8af351448d3&utm_source=ENDPOINTS%20emails&utm_term=Clinshyishycal%20Studshyies%20In%20Japan%20Toshyday%20Anshyothshyer%20Look%20At%20The%20Worlds%20Secshyond-Largest%20Preshyscripshytion%20Drug%20Marshyket%20In%20A%20Post-Panshydemshyic%20World
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.2.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
fe2c8e1464e377e0e004cae5ca02498a306b7090feddbd3abe14d088c5a7bc19
Security Headers
Name Value
Strict-Transport-Security max-age=300

Request headers

Referer
Origin
https://endpts.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

x-amz-version-id
5pOats3JozwL.Cq.YDQ1.AKeG91t1nFP
content-encoding
br
via
1.1 varnish
date
Fri, 17 Nov 2023 17:27:03 GMT
strict-transport-security
max-age=300
x-amz-request-id
5Q6XRRKFWGKJ43AR
x-amz-server-side-encryption
AES256
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
15747
x-amz-id-2
SS+LG5crvO0klR01giieEXG8nMXlTQew6CKtbvV1DwuZ6EH/qD+oBcaIbIqKQJbRChQkI+MIXZo=
x-served-by
cache-cph2320027-CPH
last-modified
Thu, 16 Nov 2023 17:54:54 GMT
server
AmazonS3
x-timer
S1700242023.243716,VS0,VE0
etag
"ee8c8948e29e77d6bade8edf829b4863"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges
bytes
x-cache-hits
10903
tc3tuo04
widget.intercom.io/widget/
7 KB
3 KB
Script
General
Full URL
https://widget.intercom.io/widget/tc3tuo04
Requested by
Host: endpts.com
URL: https://endpts.com/wp-content/plugins/endpoints/assets/js/endpoints.min.js?ver=259665458
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.84.106.92 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-52-84-106-92.bud50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
fbb4a34893d24dfb78d8ac6183949ec0b380794a0aed9ba54fdaa93488b6521e

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

x-amz-version-id
DFWv45qYo9qpoNNvnim0iMficGj2Z9vI
content-encoding
gzip
via
1.1 384ab54f8262fdb1520bb443b42f25e2.cloudfront.net (CloudFront)
date
Fri, 17 Nov 2023 17:15:13 GMT
x-amz-cf-pop
BUD50-C1
age
713
x-amz-server-side-encryption
AES256
x-cache
Error from cloudfront
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
2705
last-modified
Fri, 17 Nov 2023 12:45:06 GMT
server
AmazonS3
etag
"c5383fa331ec2fb9709b54e178c7ffd4"
vary
Accept-Encoding, Origin
content-type
application/javascript; charset=UTF-8
cache-control
max-age=900, s-maxage=900, public
accept-ranges
bytes
x-amz-cf-id
MMpzF-2WfexiktgC1auirDADjrWYVpYzMKLvOByezgnkjbDp_2bBQg==
NRJS-0a161597335a680ce50
bam.nr-data.net/1/
40 B
400 B
XHR
General
Full URL
https://bam.nr-data.net/1/NRJS-0a161597335a680ce50?a=717633112&v=1.248.0&to=YlVSMUZUCxVQV0NcWVsfcQZAXAoIHkdeW1FZVR0WRFoLFV5GUlE%3D&rst=2332&ck=0&s=c7d384909d2170b4&ref=https://endpts.com/sp/clinical-studies-in-japan-today-another-look-at-the-worlds-second-largest-prescription-drug-market-in-a-post-pandemic-world/&ap=815&be=912&fe=1269&dc=715&at=ThJRRw5OGBs%3D&fsh=1&perf=%7B%22timing%22:%7B%22of%22:1700242020953,%22n%22:0,%22f%22:596,%22dn%22:641,%22dne%22:641,%22c%22:641,%22s%22:670,%22ce%22:757,%22rq%22:757,%22rp%22:913,%22rpe%22:917,%22di%22:1590,%22ds%22:1590,%22de%22:1627,%22dc%22:2179,%22l%22:2179,%22le%22:2181%7D,%22navigation%22:%7B%7D%7D&fp=1215&fcp=1215
Requested by
Host: js-agent.newrelic.com
URL: https://js-agent.newrelic.com/nr-rum-1.248.0.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
162.247.243.29 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
c831a58c25f63105a06a622b3435bc6761474664f87e8e7b6ef8dccafa0d890f

Request headers

Referer
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
content-type
text/plain

Response headers

date
Fri, 17 Nov 2023 17:27:03 GMT
access-control-allow-methods
GET, POST, PUT, HEAD, OPTIONS
content-type
text/plain
access-control-allow-origin
https://endpts.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
Connection
keep-alive
Content-Length
40
x-served-by
cache-fra-eddf8230114-FRA
frame-modern.e128bf6a.js
js.intercomcdn.com/ Frame 8598
513 KB
142 KB
Script
General
Full URL
https://js.intercomcdn.com/frame-modern.e128bf6a.js
Requested by
Host: widget.intercom.io
URL: https://widget.intercom.io/widget/tc3tuo04
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.84.106.112 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-52-84-106-112.bud50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
adb4cd8878bf87f7fa60221be02f88daa8fda8876a0def68d90fd8ed3a6d8045
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

x-amz-version-id
bxPy0N85GvKf.eRlOLVZeTabeXzBKF0s
content-encoding
gzip
via
1.1 c179ca8f9ebae77e3e88259990d0a4e0.cloudfront.net (CloudFront)
date
Fri, 17 Nov 2023 16:45:30 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
BUD50-C1
age
2512
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
144832
last-modified
Fri, 17 Nov 2023 12:42:44 GMT
server
AmazonS3
etag
"c7761a8867bd903a362109fe3d207d33"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=31536000, s-maxage=7200, public
accept-ranges
bytes
x-amz-cf-id
FzrLp8OBxHZuQDZdgCsVd6MGFnQIRS0JfR7g9EhWNLBX4c0Pq4U_xQ==
vendor-modern.39b0b15a.js
js.intercomcdn.com/ Frame 8598
426 KB
131 KB
Script
General
Full URL
https://js.intercomcdn.com/vendor-modern.39b0b15a.js
Requested by
Host: widget.intercom.io
URL: https://widget.intercom.io/widget/tc3tuo04
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.84.106.112 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-52-84-106-112.bud50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
d6b0d063dfaebbc19c739741e85c8a273b960240b710774c74fd1947a343f6b2
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36

Response headers

x-amz-version-id
W8FVPRTKc6ymDZmFP6h1BAvX7PPx2J38
content-encoding
gzip
via
1.1 c179ca8f9ebae77e3e88259990d0a4e0.cloudfront.net (CloudFront)
date
Fri, 17 Nov 2023 16:23:34 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-amz-cf-pop
BUD50-C1
age
3815
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-storage-class
INTELLIGENT_TIERING
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
133793
last-modified
Fri, 10 Nov 2023 12:02:24 GMT
server
AmazonS3
etag
"c3d7c800929ac60bd7338a4bf9c3f40b"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=31536000, s-maxage=7200, public
accept-ranges
bytes
x-amz-cf-id
wL9NLjzCWP78NdJT8dp9upjFWWzfcwilekuLkk7FY6VMTCEtfv1oeQ==
ping
api-iam.intercom.io/messenger/web/ Frame 8598
4 KB
2 KB
XHR
General
Full URL
https://api-iam.intercom.io/messenger/web/ping
Requested by
Host: js.intercomcdn.com
URL: https://js.intercomcdn.com/frame-modern.e128bf6a.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.225.215.29 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-225-215-29.compute-1.amazonaws.com
Software
nginx /
Resource Hash
35f7cc10a3f6b912437ec8e389ebe231fd6e9c3fd1a9edc900bf6f3bb70b8c8e
Security Headers
Name Value
Strict-Transport-Security max-age=31556952; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

date
Fri, 17 Nov 2023 17:27:04 GMT
strict-transport-security
max-age=31556952; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
x-ami-version
ami-071aa90eece2139bc
status
200 OK
x-xss-protection
1; mode=block
x-request-id
0028rjkmnnss60q35sig
x-runtime
0.231228
server
nginx
etag
W/"35f7cc10a3f6b912437ec8e389ebe231"
x-request-queueing
0
vary
Accept,Accept-Encoding
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
https://endpts.com
x-intercom-version
31214a7d9786ea9dc4a784942621e2cc51e73e2f
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-frame-options
SAMEORIGIN
access-control-allow-headers
Content-Type, Idempotency-Key, X-INTERCOM-APP, X-INTERCOM-PAGE-TITLE, X-INTERCOM-USER-DATA
log_event
www.youtube.com/youtubei/v1/ Frame EB2B
28 B
61 B
XHR
General
Full URL
https://www.youtube.com/youtubei/v1/log_event?alt=json&key=AIzaSyAO_FJ2SlqU8Q4STEHLGCilw_Y9_11qcW8
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/s/player/190c935f/www-embed-player.vflset/www-embed-player.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
scaffolding on HTTPServer2 /
Resource Hash
d7d5e54ad1e33d7ab49c664323ced79cb9723ff15e9764cd0edc3e15208e8336
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/119.0.6045.159 Safari/537.36
X-Goog-Request-Time
1700242024740
Content-Type
application/json
X-YouTube-Utc-Offset
60
X-YouTube-Client-Name
56
Referer
https://www.youtube.com/embed/fkTidDPj96U?si=iIINSPEEqYqkjgEO
X-YouTube-Client-Version
1.20231114.01.00
X-YouTube-Time-Zone
Europe/Berlin
X-Goog-Visitor-Id
CgtxeWdoWFVFcFRwRSjmxN6qBjIICgJERRICEgA%3D
X-YouTube-Ad-Signals
dt=1700242022535&flash=0&frm=2&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&bc=31&bih=-12245933&biw=-12245933&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C560%2C315&vis=1&wgl=true&ca_type=image

Response headers

date
Fri, 17 Nov 2023 17:27:04 GMT
content-encoding
br
x-content-type-options
nosniff
server
scaffolding on HTTPServer2
x-frame-options
SAMEORIGIN
vary
Origin, X-Origin, Referer
content-type
application/json; charset=UTF-8
p3p
CP="This is not a P3P policy! See g.co/p3phelp for more info."
cache-control
private
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
31
x-xss-protection
0
expires
Fri, 17 Nov 2023 17:27:04 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport
Domain
www.youtube.com
URL
https://www.youtube.com/cspreport

Verdicts & Comments Add Verdict or Comment

47 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| documentPictureInPicture object| NREUM object| webpackChunk:NRBA-1.248.0.PROD object| newrelic object| _sf_async_config object| _cbq object| _wpemojiSettings function| gtag object| dataLayer object| _linkedin_data_partner_ids function| lintrk function| $ function| jQuery object| pSUPERFLY_mab object| pSUPERFLY object| google_tag_manager object| google_tag_data function| onYouTubeIframeAPIReady object| gaGlobal object| process boolean| _already_called_lintrk string| statsAPIURL object| Cookies object| mixpanel object| bootstrap object| EP_ajax_object object| ajsd object| linkPass object| epEventClient object| epTUtils undefined| asked undefined| context string| stripe_pk function| calc_crc32 function| rand function| init_tooltips object| _cb_shared object| intercomSettings function| Intercom function| validate_email object| twemoji object| wp object| ORIBILI function| __intercomAssignLocation function| __intercomReloadLocation

13 Cookies

Domain/Path Name / Value
.youtube.com/ Name: YSC
Value: 737mLLjezt0
.youtube.com/ Name: VISITOR_INFO1_LIVE
Value: qyghXUEpTpE
.endpts.com/ Name: _ga_9QWNX9N9E5
Value: GS1.1.1700242022.1.0.1700242022.60.0.0
.endpts.com/ Name: _ga
Value: GA1.1.1344095111.1700242022
.endpts.com/ Name: _cb
Value: BCjPDeDtRhjSC_rd4W
.endpts.com/ Name: _chartbeat2
Value: .1700242022568.1700242022568.1.CHiY1XBrEvvGDJFSJMBzXS2BDL2gWV.1
.endpts.com/ Name: _cb_svref
Value: null
.linkedin.com/ Name: bcookie
Value: "v=2&397e48ef-054a-4bae-8400-7a4ce6108049"
.linkedin.com/ Name: li_gc
Value: MTswOzE3MDAyNDIwMjI7MjswMjGTw/2QCH4HJWmE0JkAsLvLhsyk7l+YCndwppQJC70jyg==
.linkedin.com/ Name: lidc
Value: "b=TGST06:s=T:r=T:a=T:p=T:g=2761:u=1:x=1:i=1700242022:t=1700328422:v=2:sig=AQGJ1PbwHnhN3C_N9EgxaPlXRItQuJ-t"
.endpts.com/ Name: intercom-id-tc3tuo04
Value: 9b63b20d-789e-465a-b765-e52a8f551ab1
.endpts.com/ Name: intercom-session-tc3tuo04
Value:
.endpts.com/ Name: intercom-device-id-tc3tuo04
Value: 38984fb5-3fbd-4818-a639-f4688b2c20a5

695 Console Messages

Source Level URL
Text
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 8)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
security error (Line 6)
Message:
[Report Only] This document requires 'TrustedScript' assignment.
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://www.google.com/sorry/index?continue=https://www.youtube.com/cspreport&q=EhAgARtgAAICQDJHAAAAAAAJGObE3qoGIjDgRAkRgEWKkyVnWRsYqroyeEk7X3a76S36iVoXqq3QcavbZUpKn8iy3R9Qo4mjnScyBj5qY25kcloBQw
Message:
Failed to load resource: net::ERR_FAILED

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=2592000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

api-iam.intercom.io
api.stats.endpts.com
bam.nr-data.net
cdn.mxpnl.com
e.endpointsnews.com
endpts.com
fonts.gstatic.com
googleads.g.doubleclick.net
i.ytimg.com
jnn-pa.googleapis.com
js-agent.newrelic.com
js.intercomcdn.com
ping.chartbeat.net
px.ads.linkedin.com
px4.ads.linkedin.com
region1.analytics.google.com
snap.licdn.com
static.chartbeat.com
static.doubleclick.net
stats.g.doubleclick.net
widget.intercom.io
www.google.com
www.google.de
www.googletagmanager.com
www.gstatic.com
www.youtube.com
yt3.ggpht.com
www.youtube.com
13.107.42.14
151.101.2.137
162.247.243.29
2001:4860:4802:32::36
2600:1901:0:498c::
2600:9000:2050:d600:18:1fcd:353:c61
2620:1ec:21::14
2a00:1450:4001:803::200a
2a00:1450:4001:806::2016
2a00:1450:4001:809::2008
2a00:1450:4001:80f::2003
2a00:1450:4001:812::2003
2a00:1450:4001:813::2006
2a00:1450:4001:81c::2001
2a00:1450:4001:81c::2004
2a00:1450:4001:827::2002
2a00:1450:4001:82b::200e
2a00:1450:400c:c00::9b
2a02:26f0:3500:16::215:149b
34.225.215.29
50.17.168.97
52.4.243.120
52.84.106.112
52.84.106.92
54.183.0.47
99.86.91.113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